In the present study, we showed that primary MCL cells displayed a constitutive and BCR-induced activation of LYN and that treatment with dasatinib or with a more specific inhibitor of LYN suppressed both BCR-induced JNK phosphorylation and EGR-1 upregulation and is associated with a decrease of cell survival. This evidence concerns the gene LYN and mantle cell lymphoma.